LF LF LF LF LF LF
ons
CopyrightLFCengageLFLearning.LFPoweredLFbyLFCogn PageLF1
ero.
,Chapter 1 Consumer Safety and Drug Regulati
LF LF LF LF LF LF
onsA client calls her primary care provider requesting a prescription for an antidepressant medication. She
1. LF LF LF LF LF LF LF LF LF LF LF LF LF LF L
tellsthe nurse that she is severely depressed and would like the prescription called in to her local pharm
F F
L LF LF LF LF LF LF LF LF LF LF LF LF LF LF LF LF LF
acy. How should the nurse respond?
LF LF LF LF LF
a. The nurse encourages the client to see a psychiatric professional for an evaluation to obtai
LF LF LF LF LF LF LF LF LF LF LF LF LF LF
n theprescription.
LF F
L
b. The nurse tells the client to ask the pharmacist to recommend an over-the-counter antidepressant.
LF LF LF LF LF LF LF LF LF LF LF LF LF
c. The nurse can offer to write the client a prescription if it is a refill.
LF LF LF LF LF LF LF LF LF LF LF LF LF LF
d. The nurse offers to give the client a few samples to use until her next appointment.
LF LF LF LF LF LF LF LF LF LF LF LF LF LF LF
ANSWER: a
FEEDBACK:
a. The client should be encouraged to seek a psychiatric professional evaluation
LF LF LF LF LF LF LF LF LF LF LF
to obtainthe prescription.
LF LF L
F LF
b. Antidepressants are not sold as over-the- LF LF LF LF LF
counter medications; a prescription is required.Try again.
LF LF LF LF LF L
F LF
c. The nurse cannot write a prescription without evaluating the client. Try again.
LF LF LF LF LF LF LF LF LF LF LF
d. Samples are not given out to a client who has not been evaluated by a practition
LF LF LF LF LF LF LF LF LF LF LF LF LF LF LF
er. Tryagain.
LF L
F
POINTS: 1
QUESTION TYPE: LF Multiple Choice
L F LF
HAS VARIABLES:
LF L F False
DATE CREATED: LF 11/26/2017 8:16 PM LF LF
DATE MODIFIED: LF L F11/26/2017 8:32 PM LF LF
2. A client visits her health care provider for her annual physical. She questions the nurse regarding the
LF LF LF LF LF LF LF LF LF LF LF LF LF LF LF LF LF
use ofan herbal supplement that she saw advertised on television for weight loss. What information can
LF F
L LF LF LF LF LF LF LF LF LF LF LF LF LF LF LF
the nurse share with her client?
LF LF LF LF LF
a. The production of herbal medicines is not regulated by the FDA.
LF LF LF LF LF LF LF LF LF LF
b. Under the Dietary Supplement Health and Education Act of 1994 (DSHEA), the FDA is respon
LF LF LF LF LF LF LF LF LF LF LF LF LF LF
siblefor ensuring that a dietary supplement is safe before it is marketed.
F
L LF LF LF LF LF LF LF LF LF LF LF
c. Herbal medicines are tested by the FDA to determine if they have interactions with prescr
LF LF LF LF LF LF LF LF LF LF LF LF LF LF
ibedmedications. F
L
d. Herbal medicines, while not approved by the FDA, are considered harmless.
LF LF LF LF LF LF LF LF LF LF
ANSWER: a
FEEDBACK: a. The production of herbal medicines is not regulated by the FDA.
LF LF LF LF LF LF LF LF LF LF LF
b. Under the Dietary Supplement Health and Education Act of 1994 (DSHEA), the di
LF LF LF LF LF LF LF LF LF LF LF LF
etarymanufacturer is responsible for ensuring that a dietary supplement is safe be
L
F LF LF LF LF LF LF LF LF LF LF LF
fore it is marketed. Try again.
LF LF LF LF LF
c. The FDA does not test supplements. Try again.
LF LF LF LF LF LF LF
d. There are documented interactions with specific herbal supplements and prescr
LF LF LF LF LF LF LF LF LF
ibedmedications. Try again.
L
F LF LF
POINTS: 1
QUESTION TYPE: LF Multiple Choice
L F LF
HAS VARIABLES:
LF L F False
DATE CREATED: LF 11/26/2017 8:22 PM LF LF
DATE MODIFIED: LF L F11/26/2017 8:32 PM LF LF
CopyrightLFCengageLFLearning.LFPoweredLFbyLFCogn PageLF2
ero.
, Chapter 1 Consumer Safety and Drug Regulati
LF LF LF LF LF LF
ons
3. Upon leaving the exam room, a client tells the nurse that she is confused regarding her prescription. She
LF LF LF LF LF LF LF LF LF LF LF LF LF LF LF LF LF
asks the nurse if a cheaper, generic drug will be weaker than her current prescription. How should the nur
LF LF LF LF LF LF LF LF LF LF LF LF LF LF LF LF LF LF LF
se respond?
LF
a. Drug standards assure consumers that the same drug must be of uniform strength, quality, and purity.
LF LF LF LF LF LF LF LF LF LF LF LF LF LF LF
b. The prescribed medication is of better quality but will cost more.
LF LF LF LF LF LF LF LF LF LF
c. The insurance companies mandate there are different strengths between generic and brand n
LF LF LF LF LF LF LF LF LF LF LF LF
ameprescriptions. F
L
d. Every drug has a different chemical composition that cannot be duplicated.
LF LF LF LF LF LF LF LF LF LF
ANSWER: a
FEEDBACK:
a. Drug standards assure consumers that the same drug must be of unifor
LF LF LF LF LF LF LF LF LF LF LF LF
m strength,quality, and purity.
LF L
F LF LF
b. Generic and trade drugs are the same medication. Generic is the name that is ass
LF LF LF LF LF LF LF LF LF LF LF LF LF LF
ignedto a new drug. The trade name is the name the pharmaceutical company ass
L
F LF LF LF LF LF LF LF LF LF LF LF LF LF
igns to thatdrug to have exclusive rights to market it. Try again.
LF LF L
F LF LF LF LF LF LF LF LF LF
c. Insurance companies have no control over the production of medication. Try again.
LF LF LF LF LF LF LF LF LF LF LF
d. The laws regulating drugs state that consumers can be assured that all prepar
LF LF LF LF LF LF LF LF LF LF LF LF
ationswith the same name have the same uniform strength, quality, and purity.
L
F LF LF LF LF LF LF LF LF LF LF LF LF
Try again. LF
POINTS: 1
QUESTION TYPE: LF L F Multiple Choice LF
HAS VARIABLES:
LF L F False
DATE CREATED: LF 11/26/2017 8:23 PM LF LF
DATE MODIFIED: LF L F 11/26/2017 8:31 PM LF LF
4. The FDA, under the direction of the Department of Health and Human Services, mandates which
LF LF LF LF LF LF LF LF LF LF LF LF LF LF LF
of thefollowing?
LF F
L
a. Prescription and nonprescription drugs must be shown to be effective as well as safe.
LF LF LF LF LF LF LF LF LF LF LF LF LF
b. All labels must include a listing of active ingredients; some labels require a listing of ina
LF LF LF LF LF LF LF LF LF LF LF LF LF LF LF
ctiveingredients as well. F
L LF LF
c. All new products must be tested by the FDA before being released to the public.
LF LF LF LF LF LF LF LF LF LF LF LF LF LF
d. All drugs must have "warning" labels.
LF LF LF LF LF
ANSWER: a
FEEDBACK: a. Prescription and nonprescription drugs must be shown to be effective as well as safe.
LF LF LF LF LF LF LF LF LF LF LF LF LF LF
b. All labels must be accurate and must include a listing of all active and in
LF LF LF LF LF LF LF LF LF LF LF LF LF LF
activeingredients. Try again.
L
F LF LF
c. The FDA must approve all new products before they are released to the publi
LF LF LF LF LF LF LF LF LF LF LF LF LF
c. Tryagain.LF L
F
d. Warning labels must be present on certain preparations. Try again.
LF LF LF LF LF LF LF LF LF
POINTS: 1
QUESTION TYPE: LF L F Multiple Choice LF
HAS VARIABLES:
LF L F False
DATE CREATED: LF 11/26/2017 8:26 PM LF LF
DATE MODIFIED: LF L F 11/26/2017 8:30 PM LF LF
CopyrightLFCengageLFLearning.LFPoweredLFbyLFCogn PageLF3
ero.